Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody

Product Information
Catalog Number YR1202
Product Name Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody
Molecular Name Rovelizumab
Alias Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab
CAS Number 339086-79-2
Target ITGAL & CD11a & CD18[Homo sapiens]
Isotype IgG4
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Buffer PBS, pH7.5
Background Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.